miRNA-based diagnostics

The company beat the consensus Wall Street estimate on the top line and guided to 2018 revenues of between $21 million and $22 million.

The five-year-old firm recently completed a clinical trial of the real-time PCR-based test, called ProALL-BM, on patients from a European National Registry Study.

NEW YORK (GenomeWeb) – Cantor Fitzgerald today initiated coverage of miRNA-based diagnostics firm Rosetta Genomics with a Hold rating and a $4 price target on the company's stock.

NEW YORK (GenomeWeb) – PDI said after the close of the market Wednesday that its Interpace Diagnostics subsidiary will enter the molecular diagnostics market through the acquisition of two microRNA-based from Asuragen.

NEW YORK (GenomeWeb) – Molecular diagnostics developer DiamiR said today it has received a grant from the Michael J. Fox Foundation for Parkinson's Research for a study to validate the use of microRNA biomarkers for detecting Parkinson's early.

NEW YORK (GenomeWeb) – Trovagene has assigned all of its miRNA patents to London-based firm GenSignia IP and licensed back the technology, the San Diego-based company disclosed in its Form 10-Q filed with the US Securities and Exchange Commission recently.

NEW YORK (GenomeWeb News) – Exiqon today reported a 5 percent increase year over year in its revenues for 2013, while revenues in its fourth quarter shrank 16 percent.

NEW YORK (GenomeWeb News) –Rosetta Genomics today announced it has executed credentialing agreements with two preferred provider organizations for its Cancer Origin Test.

NEW YORK (GenomeWeb News) – Blood expression levels of a dozen microRNAs may help in distinguishing individuals affected by Alzheimer's disease from those who aren't, according to a study appearing online today in Genome Biology.

NEW YORK (GenomeWeb News) – Rosetta Genomics said after the close of the market on Thursday it and Precision Therapeutics have amended their co-marketing deal entered into in July 201

Pages

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.